In summary, there is close reciprocal relationship between obesity-associated elevations in insulin/IGF and inflammatory signaling, such that both factors should be considered in the development of interventions to improve cancer prevention and treatment in the obese patient population (Figure 4). The gene discussed is IGF1; the disease is Obesity.